RAMM Pharma Corp. (CSE:RAMM)
Canada
· Delayed Price · Currency is CAD 0.0200
0.00 (0.00%)
Mar 4, 2026, 5:15 PM EST
RAMM Pharma Cash Flow Statement
Financials in millions CAD. Fiscal year is November - October.
Millions CAD. Fiscal year is Nov - Oct.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | 2020 - 2018 |
| Net Income | -8.91 | -16.5 | -7.72 | -20.96 | -7.11 | Upgrade
|
| Depreciation & Amortization | 0.73 | 1.21 | 1.34 | 1 | 0.72 | Upgrade
|
| Other Amortization | - | - | - | 0.02 | 0.02 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.77 | - | - | - | -0.03 | Upgrade
|
| Asset Writedown & Restructuring Costs | 4.77 | 7.56 | 1.07 | 13.18 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | 0.23 | -0.27 | Upgrade
|
| Loss (Gain) on Equity Investments | - | - | - | - | 0.71 | Upgrade
|
| Stock-Based Compensation | - | 0.17 | 0.01 | 0.38 | 0.7 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.01 | -0.06 | -0.01 | 0.07 | 0.1 | Upgrade
|
| Other Operating Activities | 0.44 | 2.16 | 1.34 | 0.09 | 0.34 | Upgrade
|
| Change in Accounts Receivable | 1.08 | 0.4 | 0.51 | 1.51 | -0.22 | Upgrade
|
| Change in Inventory | 1.02 | 0.58 | -0.33 | -0.09 | 0.51 | Upgrade
|
| Change in Accounts Payable | 0.57 | 0.49 | -0.54 | -1.34 | 0.69 | Upgrade
|
| Change in Income Taxes | -0 | 0 | - | -0 | 0 | Upgrade
|
| Operating Cash Flow | -1.06 | -4 | -4.34 | -5.91 | -3.83 | Upgrade
|
| Capital Expenditures | - | -0.05 | -0.06 | -0.17 | -0.43 | Upgrade
|
| Sale of Property, Plant & Equipment | 1.22 | - | 0.15 | 0.04 | 0.03 | Upgrade
|
| Cash Acquisitions | - | - | - | -1.11 | 3.31 | Upgrade
|
| Investment in Securities | - | - | - | - | -10 | Upgrade
|
| Other Investing Activities | - | - | 0.04 | 0.09 | 0.26 | Upgrade
|
| Investing Cash Flow | 1.22 | -0.05 | 0.13 | -1.15 | -6.83 | Upgrade
|
| Long-Term Debt Repaid | -0.15 | -0.26 | -0.29 | -0.13 | -0.08 | Upgrade
|
| Net Debt Issued (Repaid) | -0.15 | -0.26 | -0.29 | -0.13 | -0.08 | Upgrade
|
| Repurchase of Common Stock | - | - | -0.17 | -0.22 | -0.09 | Upgrade
|
| Other Financing Activities | -0.01 | - | - | - | - | Upgrade
|
| Financing Cash Flow | -0.15 | -0.26 | -0.46 | -0.35 | -0.18 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.01 | 0 | 0.01 | 0.04 | -0.01 | Upgrade
|
| Net Cash Flow | -0.01 | -4.3 | -4.66 | -7.38 | -10.85 | Upgrade
|
| Free Cash Flow | -1.06 | -4.05 | -4.4 | -6.08 | -4.26 | Upgrade
|
| Free Cash Flow Margin | -31.54% | -93.17% | -86.87% | -156.02% | -103.52% | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.03 | -0.04 | -0.05 | -0.04 | Upgrade
|
| Levered Free Cash Flow | 1.03 | -2.86 | -2.31 | -3.79 | -5.03 | Upgrade
|
| Unlevered Free Cash Flow | 1.18 | -2.84 | -2.28 | -3.79 | -5.02 | Upgrade
|
| Change in Working Capital | 2.67 | 1.47 | -0.37 | 0.08 | 0.98 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.